AJNR. American journal of neuroradiology
Apr 2, 2025
BACKGROUND AND PURPOSE: Distal medium vessel occlusions (DMVOs) are estimated to cause acute ischemic stroke in 25%-40% of cases. Prognostic models can inform patient counseling and research by enabling outcome predictions. However, models designed s...
Loneliness and social isolation are distressing for individuals and predictors of mortality, yet data on their impact on publicly funded long-term care is limited. Using recent advances in natural language processing (NLP), we analysed pseudonymised ...
OBJECTIVE: Identification of clinically meaningful subphenotypes of disease progression can enhance the understanding of disease heterogeneity and underlying pathophysiology. In this study, we propose a machine learning framework to identify subpheno...
IMPORTANCE: Artificial intelligence (AI) and novel technologies, such as remote sensors, robotics, and decision support algorithms, offer the potential for improving the health and well-being of older adults, but the priorities of key partners across...
BACKGROUND: Studies on the epidemiological characteristics, treatment strategies and prognosis of nasal and paranasal sinus cancer are still relatively limited.
BMC medical informatics and decision making
Apr 1, 2025
BACKGROUND: Cognitive impairment is common after a stroke, but it can often go undetected. In this study, we investigated whether using gait and dual tasks could help detect cognitive impairment after stroke.
PURPOSE: As the global population ages, long-term/post-acute care (LTPAC) systems face challenges in ensuring quality care for older adults with complex medical needs. Using health information technology (IT) is a promising strategy to address these ...
Psychiatry and clinical neurosciences
Mar 31, 2025
AIMS: Effective intervention for mild cognitive impairment (MCI) is key for preventing dementia. As a neuroprotective agent, butylphthalide has the potential to treat MCI due to Alzheimer disease (AD). However, the pharmacological mechanism of butylp...
BACKGROUND: Alzheimer disease and related dementias (ADRD) exhibit prominent heterogeneity. Identifying clinically meaningful ADRD subtypes is essential for tailoring treatments to specific patient phenotypes.
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.